Brief: Scandinavian Chemotech Q2 Pretax Loss Narrows To SEK 4.1 Mln
Aug 13 (Reuters) - Scandinavian ChemoTech AB
CMOTECb.ST :
* Q2 NET SALES SEK 1.7 MILLION VERSUS SEK 1.2 MILLION YEAR
AGO
* Q2 PRETAX LOSS SEK 4.1 MILLION VERSUS LOSS SEK 6.4 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr9NPPvJ
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million